In this short video from CBS Boston, Dr. Robert Green shares findings from the BabySeq Project and makes the case for more screening of genetic diseases in newborns. Families who participated the BabySeq Project also share their stories.
Robert Green is interviewed by Seema Kumar, Cure CEO about The Radical Promise of Early DNA Testing for human health and longevity. He shares results from the BabySeq Project and progress on building the new start-up company, Nurture Genomics.
“In this Q&A with Will Greene, Healthcare Engagement Lead at Roche Diagnostics Asia Pacific, Dr Green talks about his pioneering work in newborn sequencing, including via the BabySeq project and the International Consortium on Newborn Sequencing (ICoNS), as well as his broader efforts to make genomic information actionable and accessible for people everywhere.”
The 2023 Precision Medicine Network (PMNET) Forum was held on October 12-13, 2023 in Riga, Latvia. PMNET’s mission is to improve patient care and outcomes by promoting development and adoption of Precision Medicine. Robert Green gave a talk about the five year follow-up of the BabySeq Project.
The 2023 Precision Medicine Network (PMNET) Forum was held on October 12-13, 2023 in Riga, Latvia. PMNET’s mission is to improve patient care and outcomes by promoting development and adoption of Precision Medicine. Robert Green shared a keynote talk during the introduction of the Forum entitled The Path to Universal Genomic Medicine.
At the 2023 International Conference on Newborn Sequencing (ICoNS), Dr. David Bick; Dr. Nidhi Shah, G2P collaborator; and Rose Heald, G2P team member, share plans to share and harmonize data amongst newborn sequencing projects internationally.
At the 2023 International Conference on Newborn Sequencing (ICoNS), Drs. Robert Green and Ingrid Holm, Co-PIs of BabySeq2, share updates on the BabySeq Project.
At the 2023 International Conference on Newborn Sequencing (ICoNS), Dr. Robert Green moderates a panel on the up and downstream ecosystem of newborn sequencing. Panelists include Dr. Vanessa Almendro from Danaher Corp, Dr. Paul Kruszka from GeneDx, and Dr. Jennifer Ibrahim from Sanofi.
Drs. Robert Green and David Bick, Co-Chairs of the International Consortium on Newborn Sequencing, share their introductory remarks at the start of ICoNS’23 in London, UK.
In this webinar Dr. Green explores the path towards a more personalized and preventive approach to medicine. He draws on insights gained from the MedSeq and BabySeq projects led by the Genomes2People Research Program (G2P).
During the first session of the National Academies of Sciences, Engineering, and Medicine Workshop entitled Next-Generation Screening – The Promise and Perils of DNA Sequencing of Newborns at Birth, Robert Green participated alongside Ellen Wright Clayton, Crystal Grant, and Mike Hu in a panel discussion moderated by Karen Weck.
During the second session of the National Academies of Sciences, Engineering, and Medicine Workshop entitled Next-Generation Screening – The Promise and Perils of DNA Sequencing of Newborns at Birth, Robert Green shared updates from the BabySeq project in his presentation: Empirical Data on the Path to Universal Newborn Sequencing. Recorded sessions of the entire NASEM workshop … Continued
On May 18-19, 2023 from 12-4pm (EST), the Newborn Screening Translational Research Network (NBSTRN) hosted a two-day virtual meeting that showcased the important role of advocacy and research in NBS. Robert Green, MD, MPH led a talk on the path to universal newborn sequencing.
Families that participated in the BabySeq Project share their stories and experiences in this short video.
Families that participated in the BabySeq Project share their stories and experiences in this short video.
The Illumina Genomics Forum is Illumina’s premier global event advancing the positive impact of genomic health. G2P Director Dr. Robert Green spoke alongside Ryan Taft on building the evidence base for offering comprehensive sequencing for every child at birth.
At the inaugural International Conference on Newborn Sequencing, researchers from eight studies across the world outlined their plans, goals, and results to date for their newborn sequencing initiatives. The BabySeq Project led by Robert Green at Brigham and Women’s Hospital, the Broad Institute and Harvard Medical School was the first randomized clinical trial designed to … Continued
PMWC, the “Precision Medicine World Conference” is the largest & original annual conference dedicated to precision medicine. At this year’s PMWC, G2P director Dr. Robert C. Green gave a talk on the path to universal newborn sequencing and disease prevention.
Through the Achieving Research Equity & Inclusion Conference, Mass General Brigham engages stakeholders from across the country and our communities for a unique opportunity to change how we do research. Click the link below to hear Dr. Robert C. Green talk about medical research in genomics, where theory meets practice.
Hear from a panel of experts, including Dr. Robert C. Green, about the challenges and opportunities ahead for genomics and precision health, as well as how researchers, clinicians and other stakeholders are working to make sure that such efforts are inclusive, equitable, accessible and effective.
“In this episode, leading medical geneticist Dr. Robert Green guides listeners through the transformative potential of genomics for personalized medicine, exploring the shift from diagnosing rare conditions to predicting common diseases. He discusses the rise of preventive genomics clinics and how detailed genetic insights can guide medical decisions, including medication selection and dosage. Dr. Green … Continued
In this debate hosted by the University of Chicago School of Medicine, Dr. Lainie Ross and Dr. Robert C. Green both respond to the question “should all newborns have their genomes sequenced at birth?”
Dr. Robert C. Green presents at the World Medical Innovation Forum on “Newborn Sequencing and Prevention of Rare Diseases: A New Public Health and Biopharma Challenge.”
On April 5th, 2022, initiatives from around the globe will virtually convene for a meeting of the Genomics in Health Implementation Forum (GHIF). This focused workshop aims to share the status of international efforts establishing genomic newborn screening programs and identify areas for engagement with GA4GH Work Streams.
Dr. Robert C. Green at the 2021 Magee-Womens Summit: The Path to Preventive Genomics.
Meet two innovative collaborators using the power of DNA to transform medicine and prevent disease. Francesco Carrozzini, filmmaker, will share his story and inspiration for the Fund dedicated to his mother and late editor for Vogue Italia, Franca Sozzani. Dr. Robert Green, professor of medicine, will present scientific evidence supporting preventive genomics. Attendees will also hear about … Continued
What Happens Next examines the future as we confront massive technological transformations in central aspects of daily life. In this video, G2P’s Dr. Robert Green shares what we’ve learned from genetic testing in healthy individuals over the past decade.
Dr. Robert Green presents at the 2021 Genomic Life Conference on “Genomic Medicine Today and the Path to Prevention.”
This free 3 day NIH sponsored conference brings academia, industry, and government together to accelerate access to gene-targeted therapies. G2P’s Dr. Robert Green co-chairs the planning committee and will be one of the speakers opening the conference on June 3 as well as speaking about BabySeq on June 10.
Augustana University and the Center for Western Studies hosted the 24th Boe Forum on Public Affairs on Monday, March 15th. This virtual event featured keynote speakers Dr. Robert Green and Dr. Jamie Metzl.
Following a screening of the NOVA documentary, “Secrets in our DNA,” the Computer History Museum hosted a panel with science and business experts about personal genetic testing. Click the link below to hear contributions by G2P director Dr. Green.
In this NOVA documentary, G2P director Dr. Green explains what DNA can reveal about our ancestry and health, and at what risk.
Dr. Robert C. Green gives talk at the December 2020 Meeting of the Advisory Committee on Heritable Disorders in Newborns and Children on “Newborn Sequencing in Genomic Medicine and Public Health (NSIGHT).”
In this talk for the National Hellenic Society, Dr. Robert Green, MD, MPH and Bethany Zettler, MS, CGC discuss the genetics of COVID vulnerability and how Genomes2People’s work has pivoted to support COVID-19 research during this pandemic.
With expert Robert Green, M.D., MPH, facilitated by Ronnie Stangler, M.D. In this presentation, Dr. Green will review exciting new findings in genomics that are revolutionizing medical care across multiple disciplines, preventing illness and extending healthy lifespan.
In the first of a two-part series, AMA Chief Experience Officer Todd Unger discusses genetics at play in COVID-19 with experts Wendy Chung, MD, PhD, Robert Green, MD, MPH, and AMA’s Chief Health and Science Officer Mira Irons, MD.
Boston researchers using COVID-19 patients’ DNA to unlock secrets about impact of virus
Meet BabySeq participants, Cora and her mom. Through our NIH-funded BabySeq Project, Cora was diagnosed with partial biotinidase deficiency, which was missed on her traditional newborn screening test. Listen to their story.
Meet Tom, a Partners HealthCare Biobank Research Participant, who was discovered to have a genetic variation for Fabry Disease. Checkout his story to understand his genes, the impacts on his healthcare and family.
Meet Brian, who through the Partners HealthCare Biobank learned that he was a carrier for familial adenomatous polyposis (FAP). Watch to learn about his journey!
